P-selectin — Drug Target
All drugs that target P-selectin — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
P-selectin inhibitor monoclonal antibody · Selectin Blocker [EPC]
Marketed (3)
- Crizanlizumab Injection · Matthew Neal MD · P-selectin inhibitor monoclonal antibody · Hematology/Oncology
Crizanlizumab is a monoclonal antibody that binds to P-selectin on the surface of platelets and endothelial cells, blocking platelet-endothelial interactions and reducing vaso-occlusive crises in sickle cell disease. - Selg1 · Novartis · Selectin Blocker [EPC] · Metabolic
Selg1 works by binding to P-selectin, preventing it from interacting with its ligands. - ADAKVEO · NOVARTIS PHARMS CORP · Selectin Blocker [EPC] · Other